BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Policy

  Concerns Over Newly-Passed Right-to-Try Legislation Were Front and Center During BIO

  Days after President Donald Trump signed the Right-to-Try legislation there are still many uncertainties about the law.

  June 14, 2018

   · 

  3 min read

   · 

  Alex Keown
• 

  BioMidwest

  Study: Common Medications Taken By U.S. Adults Could Increase Risks of Depression, Suicide

  Depression is a complex disease and occurs for a number of reasons. One reason may be the medication that people are taking.

  June 14, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Pharm Country

  Novartis Spreads Good News About Two Drugs at European Congress of Rheumatology

  Novartis has walked into the European Congress of Rheumatology to make a case for two of its drugs, Cosentyx and canakinumab.

  June 14, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Genetown

  Another Biotech Conference, Another Party Involving Half-Naked Women Covered in Corporate Logos

  Despite an outcry over a party featuring scantily clad women at the J.P. Morgan Healthcare Conference and a subsequent about-face by its organizers, another party at a biotech conference has now assumed the mantle of infamy.

  June 14, 2018

   · 

  3 min read

   · 

  Alex Keown
• 

  Sage Therapeutics Forges $575 Million Deal With Shionogi to Market Depression Drug in Parts of Asia

  Days after the U.S. Food and Drug Administration provided an expedited path forward for Sage Therapeutics’ depression treatment SAGE-217, the company snagged a deal worth $575 million.

  June 14, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  New Jersey Approves Incentives to Woo Teva Pharmaceuticals HQ

  Teva Pharmaceutical is in the midst of a $3 billion cost-cutting plan that includes cutting jobs worldwide. New Jersey has approved a plan that would save 1,000 jobs in New Jersey and relocate the company’s U.S. headquarters to Parsippany.

  June 14, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  IBM Watson Layoffs: Is Healthcare AI Ready for Prime Time?

  IBM recently reported a round of layoffs at its Watson Health unit, which uses artificial intelligence (AI) to work in healthcare.

  June 14, 2018

   · 

  4 min read

   · 

  Mark Terry
• 

  Drug Development

  GSK’s Duo-Combo HIV Treatment Gives Positive Trial Results

  ViiV Healthcare, established in November 2009 by GlaxoSmithKline, Pfizer and Shiongi, reported positive results from its Phase III GEMINI-1 and -2 clinical trials.

  June 14, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Pharm Country

  FDA Tells Mylan They Can’t (Yet) Approve its Generic to Advair

  In a brief statement, Mylan reported that the U.S. Food and Drug Administration (FDA) had informed the company that its Generic Advair Diskus had “minor deficiencies” that would be in a Complete Response Letter.

  June 14, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Deals

  With Headway in NASH, Madrigal Pharma is Considering Sale

  Reportedly, Madrigal Pharmaceuticals is considering a sale. After receiving interest from other big drug companies, the nine-employee company is evaluating its options.

  June 14, 2018

   · 

  3 min read

   · 

  Mark Terry